These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 22520648)
41. Conserved motifs in the hypervariable domain of chikungunya virus nsP3 required for transmission by Aedes aegypti mosquitoes. Göertz GP; Lingemann M; Geertsema C; Abma-Henkens MHC; Vogels CBF; Koenraadt CJM; van Oers MM; Pijlman GP PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006958. PubMed ID: 30412583 [TBL] [Abstract][Full Text] [Related]
42. Characterization of synthetic Chikungunya viruses based on the consensus sequence of recent E1-226V isolates. Scholte FE; Tas A; Martina BE; Cordioli P; Narayanan K; Makino S; Snijder EJ; van Hemert MJ PLoS One; 2013; 8(8):e71047. PubMed ID: 23936484 [TBL] [Abstract][Full Text] [Related]
43. Detection, isolation, and characterization of chikungunya viruses associated with the Pakistan outbreak of 2016-2017. Liu SQ; Li X; Zhang YN; Gao AL; Deng CL; Li JH; Jehan S; Jamil N; Deng F; Wei H; Zhang B Virol Sin; 2017 Dec; 32(6):511-519. PubMed ID: 29285673 [TBL] [Abstract][Full Text] [Related]
44. Importance of mosquito "quasispecies" in selecting an epidemic arthropod-borne virus. Vazeille M; Zouache K; Vega-Rúa A; Thiberge JM; Caro V; Yébakima A; Mousson L; Piorkowski G; Dauga C; Vaney MC; Manni M; Gasperi G; de Lamballerie X; Failloux AB Sci Rep; 2016 Jul; 6():29564. PubMed ID: 27383735 [TBL] [Abstract][Full Text] [Related]
45. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates. Akhrymuk I; Lukash T; Frolov I; Frolova EI J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275 [TBL] [Abstract][Full Text] [Related]
46. The chikungunya virus E1 glycoprotein fusion loop and hinge alter glycoprotein dynamics leading to cell and host specific changes in infectivity. Thannickal SA; Battini L; Spector SN; Noval MG; Álvarez DE; Stapleford KA bioRxiv; 2023 Nov; ():. PubMed ID: 37961096 [TBL] [Abstract][Full Text] [Related]
47. Variation at position 350 in the Chikungunya virus 6K-E1 protein determines the sensitivity of detection in a rapid E1-antigen test. Tuekprakhon A; Nakayama EE; Bartholomeeusen K; Puiprom O; Sasaki T; Huits R; Luplertlop N; Kosoltanapiwat N; Maneekan P; Ariën KK; Shioda T; Leaungwutiwong P Sci Rep; 2018 Jan; 8(1):1094. PubMed ID: 29348674 [TBL] [Abstract][Full Text] [Related]
48. Chikungunya virus fusion properties elucidated by single-particle and bulk approaches. van Duijl-Richter MKS; Blijleven JS; van Oijen AM; Smit JM J Gen Virol; 2015 Aug; 96(8):2122-2132. PubMed ID: 25872739 [TBL] [Abstract][Full Text] [Related]
49. Chikungunya virus adaptation to a mosquito vector correlates with only few point mutations in the viral envelope glycoprotein. Arias-Goeta C; Moutailler S; Mousson L; Zouache K; Thiberge JM; Caro V; Rougeon F; Failloux AB Infect Genet Evol; 2014 Jun; 24():116-26. PubMed ID: 24681263 [TBL] [Abstract][Full Text] [Related]
50. Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high pH threshold for membrane fusion in viral fitness. Fredericksen BL; Whitt MA Virology; 1998 Jan; 240(2):349-58. PubMed ID: 9454708 [TBL] [Abstract][Full Text] [Related]
51. Evaluation of Chikungunya diagnostic assays: differences in sensitivity of serology assays in two independent outbreaks. Yap G; Pok KY; Lai YL; Hapuarachchi HC; Chow A; Leo YS; Tan LK; Ng LC PLoS Negl Trop Dis; 2010 Jul; 4(7):e753. PubMed ID: 20651930 [TBL] [Abstract][Full Text] [Related]
52. Differential susceptibility & replication potential of Vero E6, BHK-21, RD, A-549, C6/36 cells & Sudeep AB; Vyas PB; Parashar D; Shil P Indian J Med Res; 2019 Jun; 149(6):771-777. PubMed ID: 31496530 [TBL] [Abstract][Full Text] [Related]
53. Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins. Liu L; Celma CC; Roy P Virol J; 2008 Jul; 5():82. PubMed ID: 18638365 [TBL] [Abstract][Full Text] [Related]
54. Genome-Wide Screening Uncovers the Significance of N-Sulfation of Heparan Sulfate as a Host Cell Factor for Chikungunya Virus Infection. Tanaka A; Tumkosit U; Nakamura S; Motooka D; Kishishita N; Priengprom T; Sa-Ngasang A; Kinoshita T; Takeda N; Maeda Y J Virol; 2017 Jul; 91(13):. PubMed ID: 28404855 [TBL] [Abstract][Full Text] [Related]
55. Expression of HCV E1 protein in baculovirus-infected cells: effects on cell viability and apoptosis induction. Ciccaglione AR; Marcantonio C; Costantino A; Equestre M; Rapicetta M Intervirology; 2003; 46(2):121-6. PubMed ID: 12684551 [TBL] [Abstract][Full Text] [Related]
56. Effects of mutations in the rubella virus E1 glycoprotein on E1-E2 interaction and membrane fusion activity. Yang D; Hwang D; Qiu Z; Gillam S J Virol; 1998 Nov; 72(11):8747-55. PubMed ID: 9765418 [TBL] [Abstract][Full Text] [Related]
57. Conformational changes in Chikungunya virus E2 protein upon heparan sulfate receptor binding explain mechanism of E2-E1 dissociation during viral entry. Sahoo B; Chowdary TK Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31167876 [TBL] [Abstract][Full Text] [Related]
58. Suramin Inhibits Chikungunya Virus Entry and Transmission. Ho YJ; Wang YM; Lu JW; Wu TY; Lin LI; Kuo SC; Lin CC PLoS One; 2015; 10(7):e0133511. PubMed ID: 26208101 [TBL] [Abstract][Full Text] [Related]